StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.96−0.06 (-2.97%)

Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –

Compugen net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was $35.34M. The highest annual figure on record is $35.34M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$35.34M–
FY2024Dec 31, 2024-$14.23M–
FY2023Dec 31, 2023-$18.75M–
FY2022Dec 31, 2022-$33.69M–
FY2021Dec 31, 2021-$34.20M–
FY2020Dec 31, 2020-$29.70M–
FY2019Dec 31, 2019-$27.34M–
FY2018Dec 31, 2018-$22.60M–
FY2017Dec 31, 2017-$37.07M–
FY2016Dec 31, 2016-$31.51M–
FY2015Dec 31, 2015-$20.16M–
FY2014Dec 31, 2014-$11.09M–
FY2013Dec 31, 2013-$14.08M–
FY2012Dec 31, 2012-$13.63M–
FY2011Dec 31, 2011-$12.00M–
FY2010Dec 31, 2010-$7.20M–
FY2009Dec 31, 2009-$3.83M–

More Compugen figures

See a number that looks wrong?